首页> 外文期刊>Gastroenterology >Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.
【24h】

Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.

机译:甲胎蛋白用于肝细胞癌的诊断:一颗璀璨的星星消亡。

获取原文
获取原文并翻译 | 示例
           

摘要

Until recently, hepatocellular carcinoma (HCC) was considered a geographically restricted cancer that affected specific regions of the world where a combination of viral infections, aflatoxin intake and alcohol consumption are highly prevalent. This has changed: HCC has a higher prevalence in South Bast Asia and sub-Saharan Africa, but its incidence has increased significantly in Europe and America, where the main risk factors are hepatitis C virus infection, alcoholism, and the metabolic syndrome. Indeed, several studies have shown that HCC is now the leading cause of death in cirrhotic patients; hence, it has become a major problem in this at-risk population.
机译:直到最近,肝细胞癌(HCC)仍被认为是一种受地理限制的癌症,它影响了世界上病毒感染,黄曲霉毒素摄入量和酒精摄入量很高的地区。这已经发生了变化:HCC在南巴斯德和撒哈拉以南非洲的患病率较高,但是在欧洲和美洲,其发病率显着增加,在欧洲和美洲,主要危险因素是丙型肝炎病毒感染,酒精中毒和代谢综合征。确实,一些研究表明,肝癌现已成为肝硬化患者的主要死亡原因。因此,这已成为该高危人群的主要问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号